Warren urges US patent office to scrutinize Merck's efforts with Keytruda

With several measures aimed at controlling rising drug prices, the Inflation Reduction Act was a long-awaited victory for the U.S. government over the pharma industry.

But the emboldened Senate isn’t stopping there. Led by Sens. Elizabeth Warren, D-Massachusetts, and Bernie Sanders, I-Vermont, lawmakers have since taken aim at a variety of pharma issues including mergers and acquisitions, offshoring profits and COVID-19 vaccine prices.